Reni Benjamin Analyst Performance

Analyst at JMP Securities

Reni Benjamin is a stock analyst at JMP Securities focused in the medical sector, covering 54 publicly traded companies. Over the past year, Reni Benjamin has issued 23 stock ratings, including buy and hold recommendations. While full access to Reni Benjamin's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Reni Benjamin's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Ranking: Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeat
Average Return: 00.00% 12-Month ROI
Success Rate: 00.00% Profitable Ratings
Total Ratings: 200 Last 11 Years
Buy Recommendations: 83.76% 165 Buy Ratings
Companies Covered: 54 Unique Companies

Ratings Distribution

Rating	Percentage	Count
Strong Buy	0.5%	0 ratings
Buy	83.2%	164 ratings
Hold	15.7%	31 ratings
Sell	0.5%	0 ratings

Out of 197 total stock ratings issued by Reni Benjamin at JMP Securities, the majority (83.2%) have been Buy recommendations, followed by 15.7% Hold, 0.5% Strong Buy, and 0.5% Sell.

Best & Worst Calls

Best Call
0000.0%
KOOL
Sep 2015
Subscribe to MarketBeat All Access to get analyst recommendation ROI.
Worst Call
000.0%
EFTR
Mar 2022
Subscribe to MarketBeat All Access to get analyst recommendation ROI.

Exchange Coverage

Exchange	Percentage	Count
NASDAQ	87.0% of companies on NASDAQ	47 companies
NYSE	9.3% of companies on NYSE	5 companies
NYSEAMERICAN	1.9% of companies on NYSEAMERICAN	1 company
OTCMKTS	1.9% of companies on OTCMKTS	1 company

Reni Benjamin, an analyst at JMP Securities, currently covers 54 companies listed on NASDAQ, NYSE, NYSEAMERICAN and OTCMKTS, with the majority traded on NASDAQ.

Coverage Focus

Sector Icon	Sector	Percentage
	Medical 48 companies	88.9%
	Miscellaneous 3 companies	5.6%
	Computer and Technology 2 companies	3.7%
	Business Services 1 company	1.9%

Reni Benjamin of JMP Securities specializes in stock coverage within the Medical sector, with additional focus on and Computer and Technology companies.

Coverage Industries

Industry	Percentage
MED - BIOMED/GENE 25 companies	46.3%
PHARMACEUTICAL PREPARATIONS 11 companies	20.4%
BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC 4 companies	7.4%
BIOTECHNOLOGY 3 companies	5.6%
Miscellaneous 3 companies	5.6%
MED - DRUGS 2 companies	3.7%
INTERNET SERVICES 1 company	1.9%
MED INSTRUMENTS 1 company	1.9%
FINANCIAL TRANSACTION SERVICES 1 company	1.9%
INTERNET SOFTWARE 1 company	1.9%
MED PRODUCTS 1 company	1.9%
LABORATORY APPARATUS & FURNITURE 1 company	1.9%

About Reni Benjamin

Dr. Reni J. Benjamin is an Equity Research Analyst at Citizens JMP Securities LLC. He is on the Board of Directors at Centre For Commercialization of Regenerative Medicine. He is covering biotechnology. He currently serves on the advisory board of Phacilitate Cell & Gene Therapy. Dr. Benjamin joins JMP Securities from Raymond James, where he was a managing director and senior research analyst. Dr. Benjamin was previously a managing director at H.C. Wainwright & Co. and Rodman & Renshaw, after starting his career in biotechnology research at Needham & Company. He is a past member of the UAB School of Health Professions Dean's Advisory Board. Dr. Benjamin holds a Ph.D. in biochemistry and molecular genetics from the University of Alabama at Birmingham and a B.S. in biology from Allegheny College.

Follow on LinkedIn

Timeframe

Start Date

End Date

Rating

12-Month ROIAll ROI

Export to Excel

Company	Report Date	Action	Report Date Price	12-Month Price Target	Rating
ALLO Allogene Therapeutics	8/4/2025	Reiterated Rating	$1.19		Market Perform
SANA Sana Biotechnology	6/24/2025	Reiterated Rating	$2.71	$5.00	Market Outperform
KURA Kura Oncology	6/4/2025	Reiterated Rating	$6.36	$28.00	Market Outperform
BPMC Blueprint Medicines	6/3/2025	Reiterated Rating	$127.69		Market Perform
TIL Instil Bio	6/2/2025	Reiterated Rating	$33.48		Market Perform
SMMT Summit Therapeutics	6/2/2025	Reiterated Rating	$17.30	$40.00	Market Outperform
LVTX LAVA Therapeutics	5/15/2025	Reiterated Rating	$1.24		Market Perform
INBX Inhibrx Biosciences	5/15/2025	Reiterated Rating	$11.84		Market Perform
IOVA Iovance Biotherapeutics	5/9/2025	Reiterated Rating	$1.72		Market Perform
BCYC Bicycle Therapeutics	5/2/2025	Lower Price Target	$9.29	$22.00	Market Outperform
PRLD Prelude Therapeutics	4/29/2025	Reiterated Rating	$0.90	$4.00	Market Outperform
KURA Kura Oncology	4/29/2025	Reiterated Rating	$6.51	$28.00	Market Outperform
BPMC Blueprint Medicines	2/14/2025	Reiterated Rating	$95.04	$125.00	Market Outperform
INCY Incyte	2/11/2025	Reiterated Rating	$66.47		Market Perform
ACET Adicet Bio	2/6/2025	Reiterated Rating	$1.03		Market Perform
KURA Kura Oncology	2/6/2025	Reiterated Rating	$8.13	$28.00	Market Outperform
UBER Uber Technologies	2/6/2025	Reiterated Rating	$67.24		Market Perform
STE STERIS	2/6/2025	Reiterated Rating	$224.65	$265.00	Market Outperform
WU Western Union	2/6/2025	Reiterated Rating	$11.32		Market Perform
WDAY Workday	2/6/2025	Reiterated Rating	$281.59	$315.00	Market Outperform
BPMC Blueprint Medicines	1/15/2025	Reiterated Rating	$107.11	$125.00	Market Outperform
INCY Incyte	1/14/2025	Reiterated Rating	$72.37		Market Perform
HOWL Werewolf Therapeutics	1/14/2025	Lower Price Target	$1.35	$4.00	Market Outperform

Stock Forecasts and Research Tools

Today's Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.